Chemical inhibitors of cyclin-dependent kinases control proliferation, apoptosis and differentiation of oligodendroglial cells

[1]  V. Gallo,et al.  Cyclin-Dependent Kinase-2 Controls Oligodendrocyte Progenitor Cell Cycle Progression and Is Downregulated in Adult Oligodendrocyte Progenitors , 2002, The Journal of Neuroscience.

[2]  Paul Greengard,et al.  Pharmacological inhibitors of cyclin-dependent kinases. , 2002, Trends in pharmacological sciences.

[3]  V. Gallo,et al.  Inhibition of Cyclin E–Cyclin-Dependent Kinase 2 Complex Formation and Activity Is Associated with Cell Cycle Arrest and Withdrawal in Oligodendrocyte Progenitor Cells , 2001, The Journal of Neuroscience.

[4]  M. Chao,et al.  p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal , 2001, EMBO reports.

[5]  B. Soliven,et al.  Regulation of cell cycle proteins by TNF-α and TGF-β in cells of oligodendroglial lineage , 2000, Journal of Neuroimmunology.

[6]  L. Nguyen,et al.  Glycine triggers an intracellular calcium influx in oligodendrocyte progenitor cells which is mediated by the activation of both the ionotropic glycine receptor and Na+‐dependent transporters , 2000, The European journal of neuroscience.

[7]  P. May,et al.  Cell cycle control and cancer. , 2000, Pathologie-biologie.

[8]  E. Sausville,et al.  Preclinical and clinical development of cyclin-dependent kinase modulators. , 2000, Journal of the National Cancer Institute.

[9]  P. Casaccia‐Bonnefil.  Cell death in the oligodendrocyte lineage: A molecular perspective of life/death decisions in development and disease , 2000, Glia.

[10]  Y. Shoshan,et al.  Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[12]  L Meijer,et al.  Properties and potential-applications of chemical inhibitors of cyclin-dependent kinases. , 1999, Pharmacology & therapeutics.

[13]  L Meijer,et al.  Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target. , 1999, Pharmacology & therapeutics.

[14]  R. DePinho,et al.  Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. , 1999, Development.

[15]  T. Jessell,et al.  Progression from Extrinsic to Intrinsic Signaling in Cell Fate Specification A View from the Nervous System , 1999, Cell.

[16]  J. Cidlowski,et al.  Cell cycle regulation and apoptosis. , 1998, Annual review of physiology.

[17]  B. Nait-Oumesmar,et al.  Expansion of rat oligodendrocyte progenitors into proliferative “oligospheres” that retain differentiation potential , 1996, Journal of neuroscience research.

[18]  Y. Shibata,et al.  p53-independent induction of apoptosis by cyclin-dependent kinase inhibition. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  David S. Park,et al.  Inhibitors of Cyclin-dependent Kinases Promote Survival of Post-mitotic Neuronally Differentiated PC12 Cells and Sympathetic Neurons (*) , 1996, The Journal of Biological Chemistry.

[20]  D. Muir,et al.  CG‐4, A new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type‐2 astrocytes , 1992, Journal of neuroscience research.

[21]  M. Raff,et al.  A cell-intrinsic timer that operates during oligodendrocyte development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  B. Soliven,et al.  Regulation of cell cycle proteins by TNF-alpha and TGF-beta in cells of oligodendroglial lineage. , 2000, Journal of neuroimmunology.

[23]  D O Morgan,et al.  Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.

[24]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.